AETHLON MEDICAL INCAEMDEarnings & Financial Report
Nasdaq
NextMay 13, 2026
AEMD Q3 2026 Key Financial Metrics
Revenue
$43.9K
Gross Profit
N/A
Operating Profit
$-2.1M
Net Profit
$-2.0M
Gross Margin
N/A
Operating Margin
-4700.4%
Net Margin
-4600.4%
YoY Growth
-26.8%
EPS
$-2.45
Financial Flow
AETHLON MEDICAL INC Q3 2026 Financial Summary
AETHLON MEDICAL INC reported revenue of $43.9K for Q3 2026, with a net profit of $-2.0M (-4600.4% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $43.9K |
|---|---|
| Net Profit | $-2.0M |
| Gross Margin | N/A |
| Operating Margin | -4700.4% |
| Report Period | Q3 2026 |
AETHLON MEDICAL INC Annual Revenue by Year
AETHLON MEDICAL INC annual revenue history includes year-by-year totals (for example, 2023 revenue was $574.2K).
| Year | Annual Revenue |
|---|---|
| 2023 | $574.2K |
| 2022 | $294.2K |
Income Statement
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q2 2025 | Q3 2025 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $574245 | $95146 | $59964 | $22730 | $43871 |
| YoY Growth | N/A | N/A | N/A | 4278.2% | N/A | N/A | -76.1% | -26.8% |
Balance Sheet
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q2 2025 | Q3 2025 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $17.1M | $23.0M | $20.7M | $17.5M | $8.8M | $6.5M | $7.3M | $8.1M |
| Liabilities | $2.2M | $3.2M | $3.4M | $2.4M | $2.8M | $2.2M | $1.6M | $1.3M |
| Equity | $15.1M | $19.9M | $17.3M | $15.1M | $6.0M | $4.3M | $5.7M | $6.7M |
Cash Flow
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q2 2025 | Q3 2025 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.7M | $-2.9M | $-2.0M | $-2.9M | $-2.2M | $-2.0M | $-1.7M | $-1.9M |